O-nitro aryl methoxycamptothecine anoxic activated prodrug used for antitumor drug
A nitroarylmethoxy camptotheca, hypoxia-activated prodrug technology, applied in the field of antitumor drugs, can solve problems such as toxic side effects, insoluble, unstable plasma metabolism, etc., and achieve low toxic side effects, high selectivity, high The effect of improving water solubility and stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] Embodiment 1. o-nitrobenzyl SN-38 and its preparation method
[0064] 1) The chemical name of o-nitrobenzyl SN-38 is:
[0065] (4S)-4,11-Diethyl-4-hydroxy-9-(2-nitrobenzyloxy)-1H-pyrano[3',4':6,7]indoleazino[1 ,2-b] quinoline-3,14(4H,12H)-dione
[0066] The chemical structural formula is:
[0067]
[0068] 2) The preferred preparation method of o-nitrobenzyl SN-38:
[0069] Prepared by reaction of o-nitrobenzyl bromide and SN-38
[0070] Dissolve 4.75 g of o-nitrobenzyl bromide and 3.92 g of SN-38 in 40 ml of N,N-dimethylformamide, add 1.38 g of potassium carbonate at room temperature, raise the temperature to 85°C after the addition, and stir for 5 hours , the system was cooled to room temperature. Add 200 ml of dichloromethane and 200 ml of water, separate the organic phase, and extract the aqueous layer with dichloromethane (50 ml × 3); combine the organic phases and dry them with anhydrous sodium sulfate, remove the solvent under reduced pressure, and obtai...
Embodiment 2
[0076] Example 2. The application effect of o-nitrobenzyl SN-38 and its comparison with the standard drug irinotecan of camptothecin derivatives
[0077] 1) Identification of anticancer activity of o-nitrobenzyl SN-38 and comparative analysis with irinotecan:
[0078] image 3 It shows the growth of subcutaneous liver cancer HepG2 tumor in nude mice after treatment with o-nitrobenzyl SN-38 and irinotecan, and the comparative analysis with the growth of tumor in the control group.
[0079] 1 × 106 human liver cancer HepG2 cells in logarithmic growth phase were subcutaneously injected into the left flank of 6-week-old female Balb / c nude mice. When the tumor grew to 100 mm3 (day 0), the animals were randomly divided into three groups, namely the control group, the irinotecan group and the o-nitrobenzyl SN-38 group, and were given intraperitoneal injection of normal saline, irinotecan (50mg / kg, sorbitol / lactic acid buffer [45 mg / ml sorbitol / 0.9 mg / ml lactic acid] and o-nitro...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 